Tribromsalan
Tribromsalan (TBS, 3,4,5-tribromosalicylanilide) is a halogenated salicylanilide with antibacterial and antifungal properties that disrupts microbial membrane integrity and inhibits enzyme systems through electrophilic reactivity. It was used as an antimicrobial ingredient in soaps and personal care products but was banned in the United States by the FDA due to photocontact sensitization causing photoallergic contact dermatitis and lack of proven clinical benefit over plain soap. It represents an early antimicrobial triclosan-related agent with unacceptable safety profile.
Molekularmasse
449,9200 g/mol
LogP
5,00
TPSA
49,30 Ų
Lipinski-Regel der Fünf
Bestanden
Pharmacokinetics (PK)
Pharmacodynamics (PD)
2D-Struktur
Cite this structure
Embed this structure
SMILES
O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O
InChI
InChI=1S/C13H8Br3NO2/c14-7-1-3-9(4-2-7)17-13(19)10-5-8(15)6-11(16)12(10)18/h1-6,18H,(H,17,19)
Molecular Formula
C13H8Br3NO2
HBD / HBA
2 / 2
Rotierbare Bindungen
2
Schwere Atome
19
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
Tribromsalan (TBS, 3,4,5-tribromosalicylanilide) is a halogenated salicylanilide with antibacterial and antifungal properties that disrupts microbial membrane integrity and inhibits enzyme systems through electrophilic reactivity. It was used as an antimicrobial ingredient in soaps and personal care products but was banned in the United States by the FDA due to photocontact sensitization causing photoallergic contact dermatitis and lack of proven clinical benefit over plain soap. It represents an early antimicrobial triclosan-related agent with unacceptable safety profile.
Yes, Tribromsalan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL24944. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 14868. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tribromsalan"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tribromsalan/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tribromsalan/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tribromsalan/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tribromsalan"></drugfyi-drug>